Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes

Clinical trial NCT07228624 · RECRUITING

Trial details

NCT number: NCT07228624
Sponsor: Fred Hutchinson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic/Myeloproliferative Neoplasm Primary Myelofibrosis Secondary Myelofibrosis

Start date: 2026-02-04
Primary completion: 2030-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.